awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37352435-1CF7DB1E-2201-4249-9CDF-B0FCA3F9AF73
Q37352435-1CF7DB1E-2201-4249-9CDF-B0FCA3F9AF73
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37352435-1CF7DB1E-2201-4249-9CDF-B0FCA3F9AF73
A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy
P2860
Q37352435-1CF7DB1E-2201-4249-9CDF-B0FCA3F9AF73
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37352435-1CF7DB1E-2201-4249-9CDF-B0FCA3F9AF73
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ffb6c45bc0e1bb12ff108f548ff57fb8a7398ce1
P2860
HGF rescues colorectal cancer cells from EGFR inhibition via MET activation